* Reviva Pharmaceuticals press release [https://seekingalpha.com/pr/20202002-reviva-reports-second-quarter-2025-financial-results-and-recent-business-highlights] (NASDAQ:RVPH [https://seekingalpha.com/symbol/RVPH]): Q2 GAAP EPS of -$0.12 in-line.
* Shares +3.24% AH.
MORE ON REVIVA PHARMACEUTICALS
* Reviva Pharmaceuticals holdings announces pricing of $10M public offering [https://seekingalpha.com/news/4462729-reviva-pharmaceuticals-holdings-announces-pricing-of-10m-public-offering]
* Seeking Alpha’s Quant Rating on Reviva Pharmaceuticals [https://seekingalpha.com/symbol/RVPH/ratings/quant-ratings]
* Historical earnings data for Reviva Pharmaceuticals [https://seekingalpha.com/symbol/RVPH/earnings]
* Financial information for Reviva Pharmaceuticals [https://seekingalpha.com/symbol/RVPH/income-statement]
Reviva Pharmaceuticals GAAP EPS of -$0.12 in-line
Published 2 months ago
Aug 14, 2025 at 9:25 PM
Positive
Auto